Amanda Williams, MD, MPH, FACOG, Interim Chief Medical Officer at March of Dimes, discusses the reported increase in the number of US counties with no obstetric care providers.

Female veterans with PTSD are twice as likely to experience early menopause and related health risks, according to a study presented at the 2024 Annual Meeting of The Menopause Society.

In a recent study presented at the 2024 Annual Meeting of The Menopause Society, 59% of nocturnal hot flashes occurred during the second half of the night, a time linked to increased cardiovascular disease risk.

A study presented at the 2024 Annual Meeting of The Menopause Society, found that women who reported physical intimate partner violence also demonstrated decreased working memory performance over time.

Data presented at the 2024 Annual Meeting of The Menopause Society highlighted greater reductions in hot flash severity among women receiving clinical hypnosis compared to those receiving cognitive behavioral therapy.

In a recent study, women with urinary incontinence were more likely to experience postpartum depression at both under and over 6 months after delivery.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

The advisory committee meeting will discuss the potential approval of oral sulopenem etzadroxil/probenecid tablets for treating urinary tract infections in women aged 18 years and older.

A recent study reveals that consuming fish during pregnancy is associated with a reduced risk of autism in children, while omega-3 supplements show no significant benefit.

In a recent study, neurodevelopmental outcomes did not significantly differ among children exposed to metformin in utero vs those unexposed.

In a recent study, women with higher levels of per- and polyfluoroalkyl substances during pregnancy reported increased weight and body fat later in life.

In this last episode, our panel discusses this patient population and the challenges around keeping them in the continuum of care.

The new single-handed inserter by CooperSurgical streamlines the placement of Paragard, a hormone-free IUD with over 30 years of proven efficacy, enhancing accessibility for both health care providers and patients.

In a recent study, rates of 12-month or longer contraceptive supply were increased by the implementation of a 12-month contraceptive supply policy.

In a recent study, the odds of adverse pregnancy outcomes were significantly increased in pregnancies of women with solid organ transplants.

Designed specifically for new mothers, Cool Mom gel packs offer a soft, non-toxic, and eco-friendly solution to postpartum discomfort, combining innovation with practical comfort.

In a recent study, reduced aging discrepancies were observed in postmenopausal women reporting hormone therapy use vs nonusers.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

In a recent study, only mothers with a COX1 rs1330344 TT genotype had reduced offspring atopic dermatitis risk following fish oil supplementation.

In this episode, clinicians discuss challenges associated with these topics and offer some insights on them.

Jean Dubuisson, MD, PhD, head of the gynecological surgery unit at Geneva University Hospitals, discusses the first successful hysterectomy performed using the MIRA surgical system.

Astellas Pharma has announced the first dose administration of fezolinetant to manage moderate to severe vasomotor symptoms in breast cancer patients using adjuvant endocrine therapy.

The CDC's latest guidelines for the 2024 to 2025 influenza season include updates to vaccine composition and specific recommendations for high-risk groups, including children, pregnant persons, and solid organ transplant recipients.

In a recent study, older women receiving messages about breast cancer screening cessation were more likely to support stopping screening than those who did not receive a message.

In a recent study, women overdue for cervical cancer and colorectal cancer screening were more likely to receive coverage when offered during their breast cancer screening visit.